JanOne Inc. (JAN)
Company Description
JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction.
It operates through Biotechnology and Recycling segments. The company's lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain.
It also provides turnkey appliance recycling and replacement services for utilities and other sponsors of energy efficiency programs.
The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019.
JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.
Country | United States |
Founded | 1976 |
Industry | Waste Management |
Sector | Industrials |
Employees | 199 |
CEO | Tony Isaac |
Contact Details
Address: 325 E. Warm Springs Road, Suite 102 Las Vegas, Nevada 89119 United States | |
Phone | 702-997-5968 |
Website | janone.com |
Stock Details
Ticker Symbol | JAN |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0000862861 |
CUSIP Number | 47089W104 |
ISIN Number | US47089W1045 |
Employer ID | 41-1454591 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Tony Isaac | President, Chief Executive Officer, Corporate Secretary and Director |
Virland A. Johnson CPA | Chief Financial Officer |
Dr. Tony Giordano Ph.D. | Chief Scientific Officer |
Cyndy L. Janzig | Director of Human Resources |
Dr. Douglas Flanagan | Chief Formulation Advisor |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 15, 2024 | 8-K | Current Report |
Feb 28, 2024 | 8-K | Current Report |
Feb 9, 2024 | 8-K/A | [Amend] Current report |
Feb 8, 2024 | 8-K | Current Report |
Jan 12, 2024 | 8-K | Current Report |
Nov 14, 2023 | 10-Q | Quarterly Report |
Oct 11, 2023 | 8-K | Current Report |
Sep 22, 2023 | 8-K/A | [Amend] Current report |
Sep 15, 2023 | 8-K | Current Report |
Aug 28, 2023 | DEF 14A | Other definitive proxy statements |